메뉴 건너뛰기
British Journal of Dermatology
Volumn 157, Issue 3, 2007, Pages 620-622
Successful treatment of primary cutaneous follicle centre lymphoma with topical 5% imiquimod [8]
Author keywords

[No Author keywords available]
Indexed keywords

CD20 ANTIBODY; CD30 ANTIGEN; CD45 ANTIGEN; CD79A ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; COMPLEMENT COMPONENT C3D RECEPTOR; IMIQUIMOD; KI 67 ANTIGEN; PROTEIN BCL 6;
EID: 34547871653     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2007.07976.x     Document Type: Letter
Times cited : (13)
References (8)
  • 1
    • 22144443170 scopus 로고    scopus 로고
    • The role of toll-like receptors in the pathogenesis and treatment of dermatological disease
    • McInturff JE, Modlin RL, Kim J. The role of toll-like receptors in the pathogenesis and treatment of dermatological disease. J Invest Dermatol 2005 125 : 1 8.
    • (2005) J Invest Dermatol , vol.125 , pp. 1-8
    • McInturff, J.E.1    Modlin, R.L.2    Kim, J.3
  • 2
    • 23044438781 scopus 로고    scopus 로고
    • Treatment of patch and plaque stage mycosis fungoides with imiquimod 5% cream
    • Deeths MJ, Chapman JT, Dellavalle RP et al. Treatment of patch and plaque stage mycosis fungoides with imiquimod 5% cream. J Am Acad Dermatol 2005 52 : 275 80.
    • (2005) J Am Acad Dermatol , vol.52 , pp. 275-80
    • Deeths, M.J.1    Chapman, J.T.2    Dellavalle, R.P.3
  • 3
    • 3142655707 scopus 로고    scopus 로고
    • Primary cutaneous CD30+ T-cell lymphoma responsive to topical imiquimod (Aldara)
    • Didona B, Benucci R, Amerio P et al. Primary cutaneous CD30+ T-cell lymphoma responsive to topical imiquimod (Aldara). Br J Dermatol 2004 150 : 1198 201.
    • (2004) Br J Dermatol , vol.150 , pp. 1198-201
    • Didona, B.1    Benucci, R.2    Amerio, P.3
  • 4
    • 20844443468 scopus 로고    scopus 로고
    • WHO-EORTC classification for cutaneous lymphomas
    • Willemze R, Jaffe ES, Burg G et al. WHO-EORTC classification for cutaneous lymphomas. Blood 2005 105 : 3768 85.
    • (2005) Blood , vol.105 , pp. 3768-85
    • Willemze, R.1    Jaffe, E.S.2    Burg, G.3
  • 5
    • 0041920772 scopus 로고    scopus 로고
    • Tumor-selective induction of apoptosis and the small-molecule immune response modifier imiquimod
    • Schon M, Bong AB, Drewniok C et al. Tumor-selective induction of apoptosis and the small-molecule immune response modifier imiquimod. J Natl Cancer Inst 2003 95 : 1138 49.
    • (2003) J Natl Cancer Inst , vol.95 , pp. 1138-49
    • Schon, M.1    Bong, A.B.2    Drewniok, C.3
  • 6
    • 0141926501 scopus 로고    scopus 로고
    • Mechanisms underlying imiquimod-induced regression of basal cell carcinoma in vivo
    • Urosevic M, Maier T, Benninghoff B et al. Mechanisms underlying imiquimod-induced regression of basal cell carcinoma in vivo. Arch Dermatol 2003 139 : 1325 32.
    • (2003) Arch Dermatol , vol.139 , pp. 1325-32
    • Urosevic, M.1    Maier, T.2    Benninghoff, B.3
  • 7
    • 2442555760 scopus 로고    scopus 로고
    • Death receptor-independent apoptosis in malignant melanoma induced by the small-molecule immune response modifier imiquimod
    • Schon MP, Wienrich BG, Drewniok C et al. Death receptor-independent apoptosis in malignant melanoma induced by the small-molecule immune response modifier imiquimod. J Invest Dermatol 2004 122 : 1266 76.
    • (2004) J Invest Dermatol , vol.122 , pp. 1266-76
    • Schon, M.P.1    Wienrich, B.G.2    Drewniok, C.3
  • 8
    • 33748334284 scopus 로고    scopus 로고
    • Topical imiquimod as treatment for different kinds of cutaneous lymphoma
    • Coors EA, Schuler G, von den Driesch P. Topical imiquimod as treatment for different kinds of cutaneous lymphoma. Eur J Dermatol 2006 16 : 391 3.
    • (2006) Eur J Dermatol , vol.16 , pp. 391-3
    • Coors, E.A.1    Schuler, G.2    Von Den Driesch, P.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.